Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001079973-25-000056·AEON Biopharma, Inc.
Schedule 13G ownership disclosure
AEON Biopharma, Inc.
Class A Common Stock, par value $0.0001 per share · CUSIP: 00791X100
Event date: 2025-01-06
- Filing-level shares
- 8,960,000.00
- Percent of class
- 9.99%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 8,960,000.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000056
- Form type
- SCHEDULE 13G
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Jan 13, 2025
- Reporting period
- Jan 06, 2025
- Description
- Schedule 13G beneficial ownership